Showing results (41-50 of 463) with videos related to
Sort By:
Pageof 47
Parkinsonism & Related Disorders|February 4, 2010
From the MPTP-treated primate to the treatment of motor complications in Parkinson's diseasePeter JennerEuropean Journal of Neurology|July 27, 2023
Stalevo® : A pioneering treatment for OFF periods in Parkinsons diseasePeter JennerParkinsonism & Related Disorders|February 8, 2003
The contribution of the MPTP-treated primate model to the development of new treatment strategies for Parkinson's diseasePeter JennerNeurology|September 25, 2003
The MPTP-treated primate as a model of motor complications in PD: primate model of motor complicationsPeter JennerMovement Disorders : Official Journal of the Movement Disorder Society|September 11, 2008
Preventing and controlling dyskinesia in Parkinson's disease--a view of current knowledge and future opportunitiesPeter JennerExpert Opinion on Investigational Drugs|July 12, 2005
Istradefylline, a novel adenosine A2A receptor antagonist, for the treatment of Parkinson's diseasePeter JennerNature Reviews. Neuroscience|August 21, 2008
Molecular mechanisms of L-DOPA-induced dyskinesiaPeter JennerTranslational Neurodegeneration|May 15, 2015
Treatment of the later stages of Parkinson's disease - pharmacological approaches now and in the futurePeter JennerNeurology|January 14, 2004
Avoidance of dyskinesia: preclinical evidence for continuous dopaminergic stimulationPeter JennerPageof 47